SYENSQO overview

Acquisition of own shares Brussels, Belgium – March 24, 2025 - 17:45 CET In accordance with article 7:215 of the Belgian Code of Companies and Associations, Syensqo SA (“Syensqo” or the “Company”) pursues its Share Buyback Program (or the “Program”) announced on September 30, 2024, covering up to €300 million. This third tranche began on February 27, 2025 and will run until June 27, 2025 at the latest, and will cover a maximum amount of up to €50 million (of the €300 million...

Participation notification by Standard Investments LLC. Brussels, Belgium – March 11, 2025 - 8:30 CET According to Belgian transparency legislation (Law of May 2, 2007), Standard Investments LLC (co Corporation Service Company, 251 Little Falls Drive, Wilmington, DE 19808, USA) recently sent Syensqo the following transparency notifications indicating that it crossed the threshold of 3%. Here is the summary of the moves: Date on which the threshold was crossed Voting rights after the...

Syensqo to explore a potential US listing Brussels, Belgium – February 27, 2025 - 07h01 CET SYENSQO SA (the “Company”) today announced that its Board of Directors approved the exploration of a potential dual listing of its shares in the United States of America, in addition to its existing Euronext Brussels listing. During this exploratory phase, the Board of Directors will assess the feasibility and potential benefits of an additional listing, including the ability to increase Syensqo's...

Syensqo and Emulseo announce strategic partnership for advanced applications in the healthcare sector PR Newswire BORDEAUX, France, Feb. 20, 2025 Exploring new opportunities within the fast-growing market of microfluidics BORDEAUX, France , Feb. 20, 2025 /PRNewswire/ -- Syensqo, a leading specialty chemicals company, is pleased to announce a strategic partnership with Emulseo, a French company specialized in formulations for microfluidic technology - the manipulation of liquids at microscopic...

Syensqo and Emulseo announce strategic partnership for advanced applications in the healthcare sector PR Newswire BORDEAUX, France, Feb. 20, 2025 Exploring new opportunities within the fast-growing market of microfluidics BORDEAUX, France , Feb. 20, 2025 /PRNewswire/ -- Syensqo, a leading specialty chemicals company, is pleased to announce a strategic partnership with Emulseo, a French company specialized in formulations for microfluidic technology - the manipulation of liquids at microscopic...

Participation notification by Norges Bank. Brussels, Belgium – February 18, 2025 - 8:30 CET According to Belgian transparency legislation (Law of May 2, 2007), Norges Bank (Bankplassen 2, PO Box 1179 Sentrum, 0107 Oslo, Norway) recently sent Syensqo the following transparency notifications indicating that it crossed the threshold of 3%. Here is the summary of the moves: Date on which the threshold was crossed Voting rights after the transaction Equivalent financial instruments after the...

Acquisition of own shares Brussels, Belgium – February 17, 2025 - 17:45 CET In accordance with article 7:215 of the Belgian Code of Companies and Associations, Syensqo SA (“Syensqo” or the “Company”) pursues its Share Buyback Program (or the “Program”) announced on September 30, 2024, covering up to €300 million. This second tranche began on December 04, 2024 and will run until February 26, 2025 at the latest, and will cover a maximum amount of up to €50 million (of the €300...